Randomized Clinical Trial to Reduce Harm From Tobacco

NCT02328794 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6006

Last updated 2017-05-02

No results posted yet for this study

Summary

Using the NIH-funded Way to Health platform, the investigators will conduct this smoking cessation RCT among Vitality/Discovery beneficiaries. The investigators will be able to determine the effectiveness of 4 different interventions aimed at smoking cessation, two of which are incentive structures that are each grounded in behavioral economic principles. The other interventions will determine the effectiveness of various cessation aids, including electronic cigarettes and text messaging, on smoking cessation. This study will be conducted as an opt-out procedure where participants are automatically enrolled in the program but have the choice to unenroll if they so chose. This pragmatic approach will allow us to investigate the effects of such programs in an employee based population that can be easily mimicked in other employee based populations.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

E-cigarette free access

Participants in this arn will be given free access to e-cigarettes to help quit smoking

BEHAVIORAL

E-cigarette/NRT/Zyban/Chantix Choice

Participants in this arn will be given free access to cessation aids to help quit smoking

BEHAVIORAL

Outcome Incentive arm

Participants in this arm will be earn incentives across 6 months for verified abstinence.

BEHAVIORAL

Loss framing incentive arm

Participants in this arm will be told they have a pre-funded account with money that is theirs if they quit smoking.

BEHAVIORAL

Control

Participants will have access to information and advice on quitting smoking. This is a control and no actual intervention will be applied.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2016-11-05
Completion
2017-04-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02328794 on ClinicalTrials.gov